Investing

Sales of and distributions from equity method investments

Pfizer Sales of and distributions from equity method investments decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $6.31B to $0.00. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ1 2022
Last reportedQ1 2026May 5, 2026

How to read this metric

Higher proceeds indicate successful exit strategies or capital recycling from non-core investments.

Detailed definition

This represents cash inflows from the sale or liquidation of investments in entities where the company exercises signifi...

Peer comparison

Common for large corporations with diverse investment portfolios or strategic alliances.

Metric ID: investing_proceeds_from_sale_of_equity_method_investments

Historical Data

12 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q4 '24Q1 '25Q1 '26
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$3.49B$3.55B$6.31B$0.00
QoQ Change+1.7%+77.8%-100.0%
YoY Change+80.8%-100.0%
Range$0.00$6.31B
Avg YoY Growth-9.6%
Median YoY Growth-9.6%

Frequently Asked Questions

What is Pfizer's sales of and distributions from equity method investments?
Pfizer (PFE) reported sales of and distributions from equity method investments of $0.00 in Q1 2026.
How has Pfizer's sales of and distributions from equity method investments changed year-over-year?
Pfizer's sales of and distributions from equity method investments decreased by 100.0% year-over-year, from $6.31B to $0.00.
What does sales of and distributions from equity method investments mean?
Cash generated from selling stakes in companies where the firm has significant influence.